StockData
CRLBFOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31

Cresco Labs Inc.

Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 40-F on Mar 6, 2026
$0.58−0.02 (-3.13%)

Close on Oct 19, 2026

Market cap
–
P/E (TTM)
–
Dividend yield
–

Ownership

Institutional holdings as of Jun 30, 2026, from 13F filings

Held by institutions
0.0%
0M of 503M shares
Institutional holders
7
1 new, 4 sold out
Net institutional buying
-0M
In Q2 2026
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only

Shares held by institutions

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
Charles Ian Bachtell273,752,00920.20%13G (passive)Feb 9, 2024
Thomas J. Manning269,739,57420.00%13D (active)Feb 9, 2024
Robert M. Sampson267,427,39019.90%13D (active)Feb 9, 2024
Dominic Sergi200,291,564–13G (passive)Dec 31, 2023
Eminence Capital, LP17,753,7926.30%13G (passive)Dec 31, 2022

Top institutional holders

13F holdings as of Jun 30, 2026

HolderShares% of CRLBFValueChange% of portfolio
Albert D Mason Inc88,0350.02%$73.07K–0.04%
Ancora Advisors, LLC48,0280.01%$39.61K−12,1410.00%
Hantz Financial Services, Inc.9,5090.00%$8+4890.00%
Strategic Investment Solutions, Inc. /IL1,4080.00%$1.17K–0.00%
Thompson Investment Management, Inc.7250.00%$602–0.00%
Massmutual Trust Co Fsb/Adv2000.00%$166–0.00%
Sterling Capital Management LLC1320.00%$110New0.00%

Institutional buying and selling by quarter

Positions opened, added to, reduced and closed by 13F filers

QuarterHoldersShares held% of sharesNew / addedReduced / closedShares boughtShares sold
Q2 202670M0.0%1 / 11 / 40M0M
Q1 2026100M0.1%2 / 21 / 20M0M
Q4 2025100M0.1%2 / 03 / 20M0M
Q3 2025100M0.1%0 / 11 / 10M0M
Q2 2025110M0.1%1 / 21 / 20M0M
Q1 2025120M0.1%2 / 02 / 10M0M
Q4 2024110M0.1%3 / 03 / 10M0M
Q3 202490M0.1%1 / 02 / 10M0M
Q2 202490M0.1%2 / 21 / 10M0M
Q1 202480M0.1%1 / 11 / 10M0M
Q4 2023100M0.1%2 / 02 / 40M0M
Q3 2023120M0.1%1 / 12 / 40M0M